TerraBioGen Raises New Funds Through Private Placement

THIS PRESS RELEASE, REQUIRED BY APPLICABLE CANADIAN LAWS, IS NOT FOR
DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES


TerraBioGen Technologies Inc. (TSX VENTURE:TBG), a developer and marketer of
proprietary technologies for the production of organic-based, high-value
agricultural products from organic wastes, announces that it has raised
additional funding of $750,000 through a non-brokered private placement of
7,500,000 commons shares at $0.10 per share. The transaction is subject to the
approval of the TSX Venture Exchange. These funds will be used to enhance the
Company's research and development, securing its intellectual property, and for
production improvements.


The Company also announces that it has cancelled the balance of a previous $1.5
million private placement. The first tranche of that non-brokered private
placement was closed in December 2011 with the issuance of 10,000,000 shares at
a price of $0.10 per share for gross proceeds of $1,000,000 and 5,000,000
warrants exercisable at $0.15 up to June 9, 2013. 


The Company further announces that it has cancelled a Master License Agreement
("MLA") for the Middle East. Under the terms of the MLA, the licensee was
required to pay scheduled license fees but they were unable to make the required
payments. 


About TerraBioGen

Located in North Vancouver, BC, TerraBioGen Technologies Inc. is committed to
research and development to continue to improve the efficiency of its technology
and the quality of its agricultural products. It is further committed to
developing a world-wide marketing capability to ensure market acceptance of its
products.


This news release contains certain statements that may be deemed
"forward-looking" statements. Forward looking statements are statements that are
not historical facts and are generally, but not always, identified by the words
"expects", "plans", "anticipates", "believes", "intends", "estimates",
"projects", "potential" and similar expressions, or that events or conditions
"will", "would", "may", "could" or "should" occur. Although TerraBioGen believes
the expectations expressed in such forward-looking statements are based on
reasonable assumptions, such statements are not guarantees of future performance
and actual results may differ materially from those in forward looking
statements. Forward looking statements are based on the beliefs, estimates and
opinions of TerraBioGen's management on the date the statements are made. Except
as required by law, TerraBioGen undertakes no obligation to update these
forward-looking statements in the event that management's beliefs, estimates or
opinions, or other factors, should change.


THIS PRESS RELEASE, REQUIRED BY APPLICABLE CANADIAN LAWS, IS NOT FOR
DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES,
AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. THESE
SECURITIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF
1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED OR SOLD
IN THE UNITED STATES OR TO U.S. PERSONS UNLESS REGISTERED OR EXEMPT THEREFROM.

Terrabiogen Technologies (TSXV:TBG)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024